60 likes | 68 Views
Clinical diagnostic is the process of identifying a disease, condition, or injury based on the signs & symptoms a patient is having and patient's health history and physical exam. Clinical diagnostics have been also found to be valuable for the prevention, detection, and management of the disease. These tests help detect and monitor many medical conditions, such as chronic diseases, infectious diseases, and autoimmune diseases that are being used to analyze drug therapies.<br><br>
E N D
Clinical Diagnostic Market Market Size (2022) US$ 69,786.6 MN CAGR (2023 – 2030) 6.1% Market Size (2030) US$ 105,907.2 MN
Segmentation (Scope) By Test : By Product: By End User: • Instruments, • Reagents, and • Other Products • Hospital Laboratory, • Diagnostic Laboratory, • Point-of-Care Testing, and • Other End Users • Lipid Panel, • Liver Panel, • Renal Panel, • Complete Blood Count, • Electrolyte Testing, • Infectious Disease Testing, • and Other Tests © Coherent Market Insights. All Rights Reserved
Major Drivers • Growing burden of infectious and chronic diseases worldwide • Increase in use of clinical diagnostic around the world • Affordability for high-end molecular diagnostics • Limitations associated with reimbursement scenario © Coherent Market Insights. All Rights Reserved
Thermo Fisher Scientific, • F. Hoffmann-La Roche AG, • QiagenN.V, Hologic Inc., • Siemens Healthineers AG, • BioMerieuxSA, • Abbott Laboratories, • Bio-Rad Laboratories Inc., • Becton, Dickinson and Company, and • Danaher Corporation (Beckman Coulter, Inc.), among others.. Major Players © Coherent Market Insights. All Rights Reserved
Global Clinical Diagnostic Market Share (%), By Route, 2030 2030 © Coherent Market Insights. All Rights Reserved